Related Experiment Video
Updated: Mar 7, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity
Donya Mohebali1, Jason Matos2, James Ducksoon Chang3
1Department of Internal Medicine Beth Israel Deaconess Medical Center Boston MA USA.
Abstract:
Gemcitabine is a commonly used antineoplastic agent used to treat a variety of cancers with rarely reported cardiac side effects. We describe a case of a 67-year-old woman with follicular lymphoma who experienced a rarely reported side effect of gemcitabine: cardiomyopathy. This case highlights a multiple hit mechanism of myocyte damage that may occur following the use of multiple cardio-toxic agents despite their administration in doses not associated with cardiotoxicity.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Drug Toxicity: Risk factors
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

